Cargando…

Octreotide Infusion for the Treatment of Congenital Chylothorax

Congenital chylothorax is an uncommon cause of pleural effusion in the pediatric age group, and it should be kept in consideration when evaluating a neonate with pleural effusion, as it is the commonest cause of pleural effusion in this age group (Tutor, 2014). No commonly accepted guidelines have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobeisy, Sumayyah Ahmed Nezar, Alkhotani, Abdulaziz, Barzanji, Mohammed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673913/
https://www.ncbi.nlm.nih.gov/pubmed/33224547
http://dx.doi.org/10.1155/2020/8890860
Descripción
Sumario:Congenital chylothorax is an uncommon cause of pleural effusion in the pediatric age group, and it should be kept in consideration when evaluating a neonate with pleural effusion, as it is the commonest cause of pleural effusion in this age group (Tutor, 2014). No commonly accepted guidelines have been published so far regarding the management of congenital chylothorax in the neonate, but trials of octreotide have appeared to be promising (Bellini et al., 2018). We present a neonate with congenital chylothorax successfully treated with octreotide infusion.